Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
83.33 EUR | +1.08% |
|
+1.36% | -11.11% |
Jul. 08 | SANOFI : UBS maintains a Buy rating | ZD |
Jul. 03 | SANOFI : Goldman Sachs reiterates its Neutral rating | ZD |
Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 4.18 | 4.57 | 5.59 | 4.54 | 4.28 | |||||
Return on Total Capital | 5.53 | 6.01 | 7.35 | 6.08 | 5.88 | |||||
Return On Equity % | 20.2 | 9.49 | 11.77 | 7.27 | 7.3 | |||||
Return on Common Equity | 20.2 | 9.44 | 11.67 | 7.26 | 7.25 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 67.61 | 68.73 | 69.83 | 69.12 | 70.2 | |||||
SG&A Margin | 25.29 | 24.5 | 23.22 | 23.39 | 20.88 | |||||
EBITDA Margin % | 28.09 | 28.75 | 30.98 | 27.2 | 26.34 | |||||
EBITA Margin % | 24.93 | 26.03 | 28.45 | 24.82 | 24.76 | |||||
EBIT Margin % | 20.36 | 21.9 | 24.32 | 19.99 | 20.03 | |||||
Income From Continuing Operations Margin % | 33.05 | 16.03 | 18.69 | 11.81 | 12.54 | |||||
Net Income Margin % | 32.95 | 15.89 | 18.44 | 11.73 | 12.55 | |||||
Net Avail. For Common Margin % | 32.95 | 15.89 | 18.44 | 11.73 | 12.41 | |||||
Normalized Net Income Margin | 12.76 | 13.15 | 14.78 | 11.38 | 11.78 | |||||
Levered Free Cash Flow Margin | 16.82 | 18.75 | 19.85 | 17.79 | -11.16 | |||||
Unlevered Free Cash Flow Margin | 17.59 | 19.32 | 20.39 | 18.5 | -10.26 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.33 | 0.33 | 0.37 | 0.36 | 0.34 | |||||
Fixed Assets Turnover | 3.46 | 3.48 | 3.84 | 3.92 | 3.78 | |||||
Receivables Turnover (Average Receivables) | 4.67 | 5.02 | 5.38 | 5.11 | 5.1 | |||||
Inventory Turnover (Average Inventory) | 1.48 | 1.44 | 1.55 | 1.53 | 1.38 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.75 | 1.44 | 1.42 | 1.27 | 1.46 | |||||
Quick Ratio | 1.24 | 0.93 | 0.98 | 0.82 | 0.62 | |||||
Operating Cash Flow to Current Liabilities | 0.39 | 0.49 | 0.44 | 0.42 | 0.31 | |||||
Days Sales Outstanding (Average Receivables) | 78.34 | 72.78 | 67.88 | 71.43 | 71.76 | |||||
Days Outstanding Inventory (Average Inventory) | 247.13 | 254.24 | 235.59 | 239.11 | 264.85 | |||||
Average Days Payable Outstanding | 155.77 | 166.02 | 170.14 | 172.95 | 210.1 | |||||
Cash Conversion Cycle (Average Days) | 169.7 | 161 | 133.33 | 137.59 | 126.52 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 37.49 | 32.47 | 28.23 | 24.78 | 23.01 | |||||
Total Debt / Total Capital | 27.27 | 24.51 | 22.01 | 19.86 | 18.7 | |||||
LT Debt/Equity | 32.74 | 27.47 | 22.3 | 21.66 | 17.26 | |||||
Long-Term Debt / Total Capital | 23.81 | 20.74 | 17.39 | 17.36 | 14.03 | |||||
Total Liabilities / Total Assets | 44.86 | 42.59 | 40.7 | 41.21 | 41.37 | |||||
EBIT / Interest Expense | 16.58 | 23.7 | 28.02 | 17.46 | 13.84 | |||||
EBITDA / Interest Expense | 23.52 | 31.99 | 36.56 | 24.31 | 18.69 | |||||
(EBITDA - Capex) / Interest Expense | 20.79 | 27.9 | 32.48 | 21.05 | 15.98 | |||||
Total Debt / EBITDA | 2.19 | 1.94 | 1.47 | 1.44 | 1.5 | |||||
Net Debt / EBITDA | 0.9 | 1.06 | 0.59 | 0.76 | 0.86 | |||||
Total Debt / (EBITDA - Capex) | 2.48 | 2.22 | 1.66 | 1.66 | 1.75 | |||||
Net Debt / (EBITDA - Capex) | 1.02 | 1.22 | 0.66 | 0.88 | 1.01 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | -0.7 | 4.83 | 15.86 | 1.42 | 7.73 | |||||
Gross Profit, 1 Yr. Growth % | -1.53 | 6.57 | 17.73 | 0.38 | 9.13 | |||||
EBITDA, 1 Yr. Growth % | 3.34 | 7.55 | 24.98 | -10.97 | 5.31 | |||||
EBITA, 1 Yr. Growth % | 3.36 | 9.75 | 26.75 | -11.49 | 5.96 | |||||
EBIT, 1 Yr. Growth % | 11.15 | 13.08 | 28.87 | -16.63 | 9.21 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 320.35 | -49.08 | 35.12 | -35.93 | 8.94 | |||||
Net Income, 1 Yr. Growth % | 338.85 | -49.38 | 34.52 | -35.49 | 2.96 | |||||
Normalized Net Income, 1 Yr. Growth % | 11.57 | 8.38 | 30.51 | -21.94 | 14.5 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 322.94 | -49.28 | 34.55 | -35.44 | 8.55 | |||||
Accounts Receivable, 1 Yr. Growth % | -5.62 | 1.03 | 11.31 | 0.11 | -8.96 | |||||
Inventory, 1 Yr. Growth % | 4.48 | 4.35 | 2.81 | 7.88 | -2.43 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | -4.12 | 13.38 | -2.44 | 1.11 | -1.8 | |||||
Total Assets, 1 Yr. Growth % | 1.59 | 5.09 | 5.39 | -0.2 | 5.01 | |||||
Tangible Book Value, 1 Yr. Growth % | 3.46K | 7.01 | 36.41 | -32.95 | 212.56 | |||||
Common Equity, 1 Yr. Growth % | 6.9 | 8.83 | 8.89 | -0.99 | 4.68 | |||||
Cash From Operations, 1 Yr. Growth % | -3.81 | 41.84 | 0.04 | -2.55 | -11.47 | |||||
Capital Expenditures, 1 Yr. Growth % | -5.22 | 17.94 | 8.59 | 7.04 | 7.04 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 22.85 | 16.79 | 22.8 | -9.1 | -168.92 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 20.45 | 15.13 | 22.38 | -7.96 | -160.25 | |||||
Dividend Per Share, 1 Yr. Growth % | 1.59 | 4.06 | 6.91 | 5.62 | 4.26 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 2.34 | 2.03 | 10.21 | 8.4 | 4.82 | |||||
Gross Profit, 2 Yr. CAGR % | 1.85 | 2.44 | 12.01 | 8.71 | 4.57 | |||||
EBITDA, 2 Yr. CAGR % | 5.88 | 5.54 | 15.91 | 5.49 | -5.61 | |||||
EBITA, 2 Yr. CAGR % | 6.51 | 6.64 | 17.91 | 5.92 | -5.41 | |||||
EBIT, 2 Yr. CAGR % | 12.39 | 12.3 | 20.68 | 3.65 | -7.57 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 67.1 | 47.5 | -17.05 | -6.95 | -17.11 | |||||
Net Income, 2 Yr. CAGR % | 69.11 | 50.32 | -17.48 | -6.85 | -18.5 | |||||
Normalized Net Income, 2 Yr. CAGR % | 11.84 | 10.15 | 18.89 | 0.93 | -8.98 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 68.53 | 47.67 | -17.39 | -6.8 | -16.85 | |||||
Accounts Receivable, 2 Yr. CAGR % | 1.58 | -2.35 | 6.04 | 5.56 | -4.54 | |||||
Inventory, 2 Yr. CAGR % | 5.69 | 4.41 | 3.58 | 5.31 | 2.59 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 4.62 | 4.26 | 5.17 | -0.68 | -0.36 | |||||
Total Assets, 2 Yr. CAGR % | 1.39 | 3.32 | 5.24 | 2.55 | 2.37 | |||||
Tangible Book Value, 2 Yr. CAGR % | 58.72 | 338.1 | 20.82 | -4.36 | 44.77 | |||||
Common Equity, 2 Yr. CAGR % | 3.44 | 7.84 | 8.86 | 3.83 | 1.8 | |||||
Cash From Operations, 2 Yr. CAGR % | 15.88 | 16.78 | 19.12 | -1.26 | -7.12 | |||||
Capital Expenditures, 2 Yr. CAGR % | -5.86 | 5.73 | 13.17 | 7.85 | 6.46 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 22.8 | 19.88 | 19.73 | 5.65 | -23.8 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 21.36 | 17.85 | 18.68 | 6.13 | -28.01 | |||||
Dividend Per Share, 2 Yr. CAGR % | 2.1 | 2.82 | 5.48 | 6.26 | 4.93 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 1.05 | 3.17 | 6.45 | 7.2 | 4.17 | |||||
Gross Profit, 3 Yr. CAGR % | 0.66 | 3.4 | 7.3 | 7.99 | 4.91 | |||||
EBITDA, 3 Yr. CAGR % | 0.7 | 6.36 | 11.61 | 6.16 | 1.21 | |||||
EBITA, 3 Yr. CAGR % | 0.57 | 7.49 | 12.91 | 7.16 | 2.48 | |||||
EBIT, 3 Yr. CAGR % | 1.52 | 12.5 | 17.51 | 6.68 | 1.17 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 46.92 | 12.39 | 43.25 | -23.89 | -4.01 | |||||
Net Income, 3 Yr. CAGR % | 13.53 | 13.06 | 44.86 | -23.98 | -3.69 | |||||
Normalized Net Income, 3 Yr. CAGR % | 2.98 | 10.56 | 16.5 | 3.33 | 0.48 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 48.56 | 12.9 | 43.16 | -23.91 | -3.92 | |||||
Accounts Receivable, 3 Yr. CAGR % | 1.25 | 1.39 | 2 | 4.03 | 0.48 | |||||
Inventory, 3 Yr. CAGR % | 7 | 5.24 | 3.88 | 4.99 | 2.67 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 3.31 | 7.46 | 1.98 | 3.8 | -1.05 | |||||
Total Assets, 3 Yr. CAGR % | 4.69 | 2.58 | 4.01 | 3.39 | 3.37 | |||||
Tangible Book Value, 3 Yr. CAGR % | 0.57 | 40.52 | 196.94 | -0.71 | 41.93 | |||||
Common Equity, 3 Yr. CAGR % | 2.75 | 5.27 | 8.19 | 5.47 | 4.11 | |||||
Cash From Operations, 3 Yr. CAGR % | 0.32 | 23.79 | 10.91 | 11.41 | -4.79 | |||||
Capital Expenditures, 3 Yr. CAGR % | -3.33 | 1.49 | 6.67 | 11.09 | 5.45 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | -16.6 | 20.79 | 20.8 | 9.23 | -12.33 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | -15.91 | 19.27 | 19.3 | 9.04 | -15.62 | |||||
Dividend Per Share, 3 Yr. CAGR % | 1.84 | 2.75 | 4.16 | 5.52 | 5.59 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 1.4 | 2.46 | 4.62 | 5.23 | 3.31 | |||||
Gross Profit, 5 Yr. CAGR % | 1.08 | 2.33 | 5.05 | 5.49 | 3.92 | |||||
EBITDA, 5 Yr. CAGR % | 0.51 | 1.69 | 6.47 | 5.98 | 2.89 | |||||
EBITA, 5 Yr. CAGR % | -0.64 | 2.02 | 7.11 | 6.83 | 4.1 | |||||
EBIT, 5 Yr. CAGR % | 1.77 | 2.67 | 8.7 | 8.84 | 5.45 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 22.31 | 6.96 | 16.85 | 4.21 | 13.99 | |||||
Net Income, 5 Yr. CAGR % | 23.49 | 5.73 | -0.11 | 4.63 | 15.09 | |||||
Normalized Net Income, 5 Yr. CAGR % | 3.5 | 3.09 | 8.98 | 6.57 | 4.21 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 23.95 | 7.87 | 17.45 | 4.56 | 14.1 | |||||
Accounts Receivable, 5 Yr. CAGR % | 0.28 | 0.69 | 3.14 | 3.04 | -0.66 | |||||
Inventory, 5 Yr. CAGR % | 5.09 | 4.79 | 5.62 | 5.27 | 3.36 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 1.22 | 3.63 | 4.05 | 4.13 | 1.04 | |||||
Total Assets, 5 Yr. CAGR % | 2.28 | 2.81 | 4.89 | 2.57 | 3.35 | |||||
Tangible Book Value, 5 Yr. CAGR % | -4.69 | -2.15 | 8.86 | 20.47 | 122.78 | |||||
Common Equity, 5 Yr. CAGR % | 1.65 | 3.6 | 5.19 | 4.69 | 5.59 | |||||
Cash From Operations, 5 Yr. CAGR % | -3.54 | 6.07 | 7.36 | 13.08 | 3.31 | |||||
Capital Expenditures, 5 Yr. CAGR % | 0.83 | 3.94 | 2.96 | 3.97 | 5.55 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 22.55 | 5.03 | -3.62 | 14.46 | -0.66 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 21 | 4.86 | -3.48 | 13.81 | -3.58 | |||||
Dividend Per Share, 5 Yr. CAGR % | 1.78 | 2.38 | 3.28 | 4.14 | 4.47 |
- Stock Market
- Equities
- SAN Stock
- Financials Sanofi
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions